ARHS vs IDXX · P/E 14, rev $699.2M vs P/E 40, rev $2.36B
Arhaus Inc (ARHS) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Arhaus Inc (ARHS) is a specialty retail company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported ARHS revenue for 2026-06-30 was $699.2M. Net income was $41.9M. ARHS currently screens at market cap $924.3M and trailing P/E 13.9.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
ARHS currently screens at market cap $924.3M and trailing P/E 13.9. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the ARHS and IDXX stock pages for the full models.
Not investment advice.